Who
Chas McKhann
Director
Company insider
Files Form 4 as: Director, Exagen; Director, Envoy Medical; Chief Executive Officer, Silk Road Medical; President and CEO, Apollo Endosurgery; Chief Commercial Officer, Intersect ENT.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $1.0M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 2 Feb 2015
- Last trade
- 9 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 22 Jun 2026 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 9 Jun 2026filed 22 Jun 2026 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 15 Apr 2026filed 17 Apr 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Apr 2026filed 17 Apr 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Silk Road Medical | SEC FORM 4 Code D | —722,396 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Silk Road Medical | SEC FORM 4 Code A | —1,299,042 at $0.00 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Silk Road Medical | SEC FORM 4 Code D | —1,299,042 | filing |
| 1 Mar 2024filed 5 Mar 2024 | Silk Road Medical | SEC FORM 4 Code A | —110,313 at $0.00 | filing |
| 2 Nov 2023filed 3 Nov 2023 | Silk Road Medical | SEC FORM 4 Code A | —612,083 at $0.00 | filing |
| 4 Apr 2023filed 4 Apr 2023 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code D | —848,733 | filing |
| 4 Apr 2023filed 4 Apr 2023 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code D | —459,170 | filing |
| 4 Apr 2023filed 4 Apr 2023 | Apollo Endosurgery | SEC FORM 4 Code D | —689,880 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code A | —459,170 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Apollo Endosurgery | SEC FORM 4 Code A | —112,607 at $0.00 | filing |
| 5 May 2022filed 9 May 2022 | Apollo Endosurgery | SEC FORM 4 Code F | $361K66,553 at $5.42 | filing |
| 20 Aug 2021filed 20 Aug 2021 | Apollo Endosurgery | SEC FORM 4 Sold | $164K21,148 at $7.74 | filing |
| 20 Aug 2021filed 20 Aug 2021 | Apollo Endosurgery | SEC FORM 4 Sold | $164K21,148 at $7.74 | filing |
| 19 Aug 2021filed 20 Aug 2021 | Apollo Endosurgery | SEC FORM 4 Sold | $167K21,148 at $7.89 | filing |
| 19 Aug 2021filed 20 Aug 2021 | Apollo Endosurgery | SEC FORM 4 Sold | $167K21,148 at $7.89 | filing |
| 18 Aug 2021filed 20 Aug 2021 | Apollo Endosurgery | SEC FORM 4 Sold | $174K21,156 at $8.21 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.